A B S T R
From the Rockefeller University, New York 10021 A B S T R A C T Large percentages of the lymphocytes from some patients with rheumatoid arthritis and systemic lupus erythematosus were densely covered with Ig demonstrable by immunofluorescence, which was occasionally present in the form of caps. The amount and character of the Ig staining depended largely on the procedures used in the isolation and washing of the lymphocytes. Cold-reactive antilymphocyte antibodies present in many sera were primarily responsible for these variations. Overnight culture of the lymphocytes proved to be an efficient procedure for the removal of adsorbed antibody. Some evidence was also obtained for the presence of circulating immune complexes and exogenous rheumatoid factor molecules on the lymphocyte surface.
Thus on freshly isolated cells the demonstration of surface Ig proved to an unreliable marker of bone marrowderived (B) cells in these disease; the actual percent of B cells with intrinsic surface Ig was often markedly decreased. In patients with systemic lupus erythematosus, this reduction was in agreement with the low numbers of cells that had a receptor for aggregated IgG. The mean percentage of thymus-derived (T) cells in both diseases was slightly greater than the normal level.
INTRODUCTION
Considerable evidence has accumulated for a variety of immunological alterations in patients with rheumatoid arthritis (RA)' and systemic lupus erythematosus (SLE), although the basic etiologies remain unknown. Recent methodologic advances in the study of lymphocytes have furthered the understanding of a number of disorders, particularly the immunodeficiency and lymphoproliferative groups (1, 2) . Utilizing similar methods, several studies have been made of patients with RA and SLE (3) (4) (5) (6) (7) (8) (9) . Although the data of these investigators differed regarding the composition and character of the peripheral blood lymphocyte populations, the predominant conclusion was that the surface Ig-bearing lymphocytes were increased, implying an increase in the bone marrow-derived (B) cell population.
However, there are several factors present in these diseases that may complicate the interpretation of cell 'Abbreviations used in this paper: B, bursal-equivalent surface markers by interfering with the assay procedures. Antibodies to endogenous antigens, particularly those to the lymphocyte surface, and circulating immune complexes occur that may be demonstrated by direct cytotoxicity, inhibition of mixed lymphocyte cultures, and inhibition of antibody-dependent lymphocyte-mediated cvtotoxicitv (10) (11) (12) (13) (14) (15) .
In the present report, a number of methods have been employed to study the proportion of lymphocytes having B and thymus-derived (T) cell surface markers in both peripheral blood and joint fluid. Particular attention has been directed to evaluating antilymphocyte antibodies and other factors that became apparent as sources of potential interference with the determinations of the T and B cells. Isolation procedures and analyses for surface markers have been altered to minimize these effects. In the studies on joint fluids, an unusual cell type lacking detectable surface markers was examined in further detail.
METHODS
Patient selection and general procedures were as previously described (16 had active disease of a major organ system and were receiving more than 20 mg prednisone daily. Three were also receiving azathioprine or cyclophosphamide. Representative cases are summarized in Table IV. The patients were arbitrarily divided into groups according to the percentage of lymphocytes bearing surface Ig. 14 patients had more than 75% of cells with surface Ig and 10 had lower percentages. 9 of the 14 patients with the higher percentage of lymphocytes bearing surface Ig and 3 of 10 patients with the lower percentages had active disease of a major organ system. The mean lymphocyte count of the 14-patient group was 1,100/mm3, while that of the 10-patient group was 1,700/mm3. The percentage of sheep erythrocyte rosetteforming lymphocytes was 83 in each group. All patients were receiving widely varying therapies. 10 of the 14 patients with elevated lymphocyte surface Ig were receiving over 20 mg prednisone daily and 2 were receiving azathioprine or cyclophosphamide. A serial study is in progress to delineate further the relationship between the indices of disease activity and the present findings. Po (RA) 43 4 Lo (RA) 32 3 Sz (RA) 14 1 Wi (normal) 15 11 De (normal) 21 17 St (nornmal) 9 8 Freshly isolated lymphocytes were placed in RPTMI 1640 with 10% E FCS at a concentration of 5 X 106/mil. They were inCubated overnight iu 5%-CO2 at 370C. All recovery and viability exceeded 95%.-c Aliquots were then stained with rhodamineconjugated anti-Ig and the Ig-bearing lymphocytes enumerated. RA. Lymphocytes from some patients with RA had extreme amounts of Ig detectable on the cell surface, as in the findings in patients with SLE when the same method of cold isolation was used. This Ig also often differed considerably from the surface staining pattern characteristic of normal B lymphocytes. The patterns of surface Ig staining varied from fine through coarse asymmetrical patching to definite dense cap formation. The latter is illustrated in Fig. 2 a and Other joint diseases. Synovial fluids from three patients with SLE were studied. Surface Ig found was on 10, 18, and 28% of the lymphocytes. A representative case is included in Table IV . This patient had 18,000 lymphocytes/mm' of joint fluid. The other patients had less marked lymphocyte elevations. Nine additional fluids were obtained from patients with various diseases, including septic arthritides (staphlococcal and gonococcal), acute gout, and ankylosing spondylitis. The percentage of lymphocytes having surface Ig ranged from 12 to 32.
Patient information. The patient population with RA represented a group selected with considerable bias towards inclusion of patients with severe joint or extraarticular manifestations. Most of the patients had longstanding disease and had previous courses of gold salt therapy. All were receiving drugs of the analgesic-antiinflammatory class, six were receiving gold salt therapy, and eight were receiving 5 mg prednisone daily, and one 10 mg daily. Representative cases are summarized in Table IV . Grouping the patients according to high or low levels of peripheral blood lymphocyte surface Ig did not distinguish a particular group of clinical or laboratory findings.
8 of 11 patients studied showed an increased concentration of lymphocytes in the joint fluid relative to that found in the peripheral blood. The mean ratio of these concentrations was 4: 1. Examples are shown in Table  IV . In 11 of 13 joint fluids, the polymorphonuclear leukocyte was the preponderant cell. Fluid Co with 66% lymphocytes and a leukocyte count of 10,700/mm8, and fluid Tr with 92% polymorphonuclear leukocytes and a leukocyte count of 35,000/mm' represented the extreme situations found. Yet in each there was enrichment of lymphocytes in the joint fluid, of which approximately one-fourth lacked detectable surface markers. The patients receiving low-dose prednisone therapy or gold salt therapy were not distinguishable from other patients on the basis of number of lymphocytes or the proportion of cells with T or B markers. Patient Go, described in Table IV , was receiving 1.5 g penicillamine, daily for 4 mo and exhibited the lowest joint fluid lymphocyte count among all the patients. This patient did not have an increase in surface Ig on the peripheral blood lymphocytes. Most of the additional surface Ig was antibody directed to autologous plasma membrane components. Support for the antibody nature of the surface Ig was provided by experiments in which lymphocytes that had previously lost the excess surface Ig regained it after reincubation in autologous serum. In addition, a parallel study has shown that these sera contained antibodies that were similarly reactive with both normal lymphocytes and the autologous lymphocytes. This reactivity was demonstrated both by fluorescence microscopy and by cytotoxicity. Fluorescence microscopy proved to be considerably more sensitive than cytotoxicity as a means of recognizing these antibodies. These results and the further characterization of the antibodies as to class, specificity, and physical properties will be the subject of a separate report.2 Thus these antibodies are presumably related to those detected previously by lymphocytotoxicity (10) (11) (12) and mixed leukocyte culture inhibition (13, 14, 20) .
DISCUSSION
An interesting property of a large proportion of the antibodies encountered in the present study is that, while firmly adherent at 4VC, they are readily lost on incubation at higher temperatures, like cold agglutinins or coldreactive rheumatoid factors (21) . Thus they may be considered cold-reactive antilymphocyte antibodies. A lower temperature optimum of 15'C has previously been described for the lymphocytotoxins of SLE (10); however, their activity is still detectable at 370C (12) . The number of T lymphocytes was slightly increased in both diseases, as determined by erythrocyte rosette formation carried out with overnight incubation at 4VC. Performed in this manner, inhibition, presumably due to the antilymphocyte antibodies, is minimized. However, when rosette formation was tested with short periods of incubation and without the addition of AB serum, as in some laboratories, much lower levels of rosette-forming lymphocytes were found in many freshly isolated preparations. It was apparent that interfering antibodies were involved in this system as well. These effects were not apparent with lymphocytes that had been put into overnight cultures.
In a few joint fluid and peripheral blood samples from RA patients, cells bearing the aggregate receptor were found at more than twice the level of Ig-bearing B cells.
These did not diminish significantly after overnight culture and they accounted for the major portion of all nonrosetting lymphocytes in these cases. This population of lymphocytes could represent an unusual type of B cell. Another possibility is that this cell may be related to the K cell responsible for antibody-mediated cytotoxicity (7, 23, 24 Further studies are required on these points, particularly in distinguishing the antibodies with cold-enhanced reactivity from IgG antibodies, which also are known to be present in some SLE patients through their activities at 370C (10, 19) . It is possible that the antilymphocyte antibodies contribute to the lymphopenia by shortening the life-span or altering the circulatory pattern of the cells. But a potentially more significant effect of the antibodies is that they might interfere with the interplay of lymphocyte populations that occur in the normal immune response. By this means they may further the abnormal immune state that led to the production of the antilymphocyte antibodies. Another potential effect of this variety of autoantibody is that it could contribute to immune complex disease by combining with shed lymphocyte surface components that may be present in the circulation.
In the joint fluids of RA patients, an unusual cell population was evident that lacked all assayed markers. These cells formed the second major lymphocyte population, greatly exceeding the number of typical B cells in the synovial fluid. By morphologic and ultrastructural criteria, the cells appeared to be lymphocytes and their unusual properties remained stable in culture for 24 h. Cells such as these have been termed "null cells" and represent a significant population in the mouse spleen, particularly in the NZB/W hybrid animals (27, 28) .
In joint fluids, this may be a precursor cell that reflects the characteristic lymphoproliferation in the synovium or it could be a mature lymphocyte modulated by the intense immunologic reactivity of the synovial fluid. Joint fluid lymphocytes are known to respond poorly to phytohemagglutinin (29) and function poorly as both stimulator and responder in the mixed lymphocyte culture (5 (30) .
In contrast to the findings in peripheral blood, antilymphocyte antibodies were not detected on the joint fluid lymphocytes. One explanation for this could be that the antilymphocyte antibodies are present in the synovial fluid in the form of immune complexes coupled to antigenic fragments shed from the lymphocyte surface. Efforts are currently underway to determine if such postulated complexes account for a portion of the complexes previously observed in these joint fluids.
